Assertio

ASRT

ATLANTA, GA – – (Globe Newswire – February 20, 2024) – – A shareholder class action lawsuit against Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) has an upcoming March 5, 2024 Lead Plaintiff deadline. The lawsuit alleges Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the lawsuit alleges Defendants failed to disclose that: (i) the Company’s reliance on Indocin products to boost its net income was unsustainable given the risk of generic competition; (ii) the Spectrum Acquisition was less valuable than Assertio had represented to investors; (iii) accordingly, Assertio had overstated the positive impact the sale of Indocin products and the Spectrum Acquisition were likely to have on the Company’s profitability; and (iv) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

If you bought Assertio shares between March 9, 2023 and November 8, 2023, and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/assertio/ to learn more.

 

The deadline to ask the court to be appointed lead plaintiff in the case is March 5, 2024.

Registration Deadline

Lead Plaintiff Deadline Has Passed

March 5, 2024

Submit Your Information

Name(Required)
Address
Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
 
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share